For these purposes, with the support of the Akimat of the Almaty region, new technological equipment for the production of vaccines was purchased on preferential loans.

In September of this year, 300 thousand validation series of the QazVac vaccine have already been released at the Antigen site with a capacity of up to one million doses per month.

Deputy Prime Minister Yeraly Tugzhanov, as part of the instructions of the Head of State to ensure the biosafety of the country, outlined in the message to the people, got acquainted with the work of the scientific and production enterprise "Antigen". Currently, this enterprise is a partner of the Research Institute of Biological Safety Problems of the Ministry of Education and Science of the Republic of Kazakhstan.

International quality standards give the company the opportunity to achieve a high technical level, quality and reliability at all production sites.

NPP "Antigen", along with the biopharmaceutical plant at OtarBioPharm LLP, became the second production site for the production of the Kazakh QazVac vaccine developed by NIIPBB.

The company is located in the village of Abay, Karasay district, Almaty region.